Pathology AV Club

Share this post
Important news about Paps and šŸ’©
mazer.substack.com

Important news about Paps and šŸ’©

Benjamin Mazer
Dec 20, 2022
Share this post
Important news about Paps and šŸ’©
mazer.substack.com

Here are a few recent articles that I found important, interesting, or funny.

But first…

Thank you to everyone who has subscribed to this free newsletter. I am still experimenting with format, frequency, and length. Please bear with me as I get the hang of this medium.

If you subscribe to many Substacks or don’t like receiving a lot of emails, you can read your newsletters through the Substack app and website instead. I find this method to be convenient.

Ɖdouard Manet, Reclining Young Woman in SpanishĀ Costume (Yale Art Gallery)

Holiday humor…

To snooze, schmooze, peruse, booze, or learn new views: a rejected Christmas Issue research study. ā€œSelf-reported conference behavior including frequency of falling asleep (snoozing), interacting with other attendees (schmoozing), and multi-tasking (perusing) during presentations, as well as drinking (boozing) at the conference.ā€ (Preprint, 2022)

Discontinuing screening, one of the trickiest medical interventions…

Why Many Older Women Are Getting Pap Tests They Don’t Need. ā€œAll screening involves harms as well as benefits.ā€ (New York Times, 12/18/22)

Fecal transplants: hype vs reality…

Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery. ā€œIn this study, fecal microbiota transplantation did not reduce the body weight of patients undergoing bariatric surgery.ā€ (JAMA Network Open, 2022)

More evidence of changes in other infections during the pandemic…

Sustained reductions in life-threatening invasive bacterial diseases during the first two years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries participating in the IRIS Consortium. ā€œCOVID-19 containment measures were associated with a sustained decrease in the incidence of invasive disease caused by S pneumoniae, H influenzae and N meningitidis during the first two years of the pandemic, but cases began to increase in some countries as pandemic restrictions were lifted.ā€ (Preprint, 2022)

An important randomized trial…

Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The UK RECOVERY trial showed us that low-dose steroids help many patients with severe COVID. The latest results from this group show that high-dose steroids can actually harm some patients. (Preprint, 2022)

Share this post
Important news about Paps and šŸ’©
mazer.substack.com
Previous
Next
Comments
TopNewCommunity

No posts

Ready for more?

Ā© 2023 Benjamin Mazer
Privacy āˆ™ Terms āˆ™ Collection notice
Start WritingGet the app
SubstackĀ is the home for great writing